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Primary effusion lymphoma (PEL) is a subtype of non-Hodgkin lymphoma that presents as serous ef-
fusions without detectable masses or organomegaly. Here we report a case of PEL-like lymphoma in a
patient with past asbestos exposure. A 65-year-old manwas referred to our hospital due to dyspnea upon
exertion. He had been exposed to asbestos for three years in the construction industry. Chest X-ray and
CT images demonstrated left pleural effusion. Cytological analysis of the pleural effusion revealed large
atypical lymphocytes with distinct nuclear bodies and high nucleus-to-cytoplasm ratio. Immunohisto-
chemical analyses showed that the cells were CD20þ, CD3, CD5, and CD10. These ﬁndings led to a
diagnosis of diffuse large B-cell lymphoma. PEL or PEL-like lymphoma should be considered a potential
cause of pleural effusion in subjects with past asbestos exposure.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary effusion lymphoma (PEL) is a subtype of non-Hodgkin
lymphoma that presents as serous effusions without detectable
masses or organomegaly. PEL usually occurs in the setting of im-
munodeﬁciency and is associated with human herpesvirus (HHV) -
8. Here we report a case of PEL-like lymphoma in a subject with a
history of asbestos exposure.
2. Case report
A 65-year-old man was referred to our hospital due to dyspnea
upon exertion. He was an occasional smoker and had been exposed
to asbestos from 18 to 20 years old while employed in the con-
struction industry, cutting asbestos-containing building material.
Chest X-ray showed left pleural effusion (Fig. 1A), and computed
tomographic (CT) images revealed left pleural effusion and calciﬁed
pleural plaques without pleural tumor (Fig. 1B). ThoracoscopicHV, human herpesvirus; CT,
phoma.
cology, Okayama Rosai Hos-
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Ltd. This is an open access article uexploration revealed redebrown pleural effusion and plaques, but
no tumorwas detected on the pleura. Culture of the pleural effusion
was negative, and cytological examination revealed a cellular dis-
tribution of 1.0% macrophages, 1.5% neutrophils, and 97.5% lym-
phocytes. Other examinations of the ﬂuid showed nonspeciﬁc
ﬁndings. Pleural biopsy showed no evidence of malignancy.
During follow-up, the patient repeatedly exhibited accumulation
of left pleural effusion, which was treated each time with thor-
acentesis. Four years after the ﬁrst admission, analysis of pleural
effusion from the fourth thoracentesis revealed large atypical lym-
phocytes with distinct nuclear bodies and a high nucleus-to-
cytoplasm ratio (Fig. 2). Malignant lymphoma was suspected and
thoracoscopic pleural biopsy was performed again, and the biopsy
specimen from the ﬁbrin tissues attached to the parietal pleura
showed several groups of small round atypical lymphocytes. All of
acid-fast bacteria stain, PCR analysis of tuberculosis, and culture for
acid fast bacillus were negative. A culture test for standard plate
count bacteria was also negative. Immunohistochemical analyses
revealed that these cells were CD20þ (Fig. 3), CD3, CD5, and
CD10. Based on these ﬁndings, the diagnosis was conﬁrmed as
diffuse large B-cell lymphoma (DLBCL). Contrast-enhanced CT im-
aging of whole body (neck to pelvis) revealed no lymphadenopathy
or tumor. Serological tests for hepatitis-C virus, human T-cell lym-
phoma virus-1, and EpsteineBarr virus were negative, as was thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Left pleural effusion and calciﬁed pleural plaques visible on chest X-ray (A) and computed tomographic (B) images.
Fig. 2. Cytological analysis of pleural effusion revealed large atypical lymphocytes with
distinct nuclear body and high nucleus-to-cytoplasm ratio (40).
Fig. 3. Immunohistochemical analyses revealed that the cells were CD20þ (10).
N. Hara et al. / Respiratory Medicine Case Reports 16 (2015) 169e171170immunohistochemical analysis for HHV8. The patient has been
followed-up, and has shown no disease progression for 3 years.3. Discussion
The 2001 World Health Organization classiﬁcation deﬁnes PEL
as a disease entity representing a part of diffuse large B-cell lym-
phoma [1]. PEL is commonly associated with HHV8 infection [2];
however, PEL-like disease processes have recently been reported inHHV8-negative patients. Those cases are considered a rare disease
entity called HHV8-unrelated PEL-like lymphoma [3]. Advanced
age [4] remains the only known risk factor for PEL-like lymphoma,
and the pathogenic mechanisms remain unclear. It has been re-
ported that patients with HHV8-unrelated PEL-like lymphoma
show better outcomes than patients with PEL [5].
In our present case, the patient was elderly and had a past
occupational history of asbestos exposure, but showed no immu-
nological deterioration. To our knowledge, this is the ﬁrst report of
PEL-like lymphoma in a subject with past asbestos exposure. While
no association has been established between lymphoproliferative
disorder and asbestos exposure, it is possible that asbestos-induced
chronic inﬂammation, in addition to advanced age, may have
triggered lymphoproliferative disorder in the current case, though
we cannot deny the possibility that the disease developed inde-
pendently, considering relative short term of asbestos exposure.
In conclusion, here we report a rare manifestation of PEL-like
lymphoma from a subject with past asbestos exposure. Subjects
with past asbestos exposure sometimes develop pleural effusion,
and suspected diagnoses include malignant pleural mesothelioma,
lung cancer, benign asbestos pleural effusion, or tuberculous
pleuritis. Our present case suggests that PEL or PEL-like lymphoma
should also be considered as a potential cause of pleural effusion in
subjects with past asbestos exposure.
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